Emerging Knowledge on Human Immunodeficiency Virus
A special issue of Life (ISSN 2075-1729).
Deadline for manuscript submissions: 18 November 2024 | Viewed by 49
Special Issue Editors
Interests: HIV; HIV immunology; HIV therapeutics; nosocomial infections; antimicrobial resistance mechanisms; SARS-CoV-2 infection
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology; molecular epidemiology; public health; virology; AIDS/HIV; STIs; hepatitis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the guest editors of this Life Special Issue on "Emerging Knowledge on Human Immunodeficiency Virus", we invite you to submit your original research on this subject.
HIV medicine is a field with exciting developments and an active pipeline of therapeutic and basic scientific knowledge. The combination of scientific knowledge and its implementation, which has been coupled with engaging communities and state and global entities in planning and allocating resources, has changed the landscape of HIV medicine. However, there is still a great deal of work to carry out in the quest for better treatment and management strategies.
The global management of HIV infections comprises an ever-changing puzzle of basic research, therapeutic developments, social action against stigma, and the involvement of communities and global organizations. It is one of the most multi-faceted and multi-factorial fields in contemporary medicine, with a profound impact on millions of human lives.
From our two complementing sides of the HIV research spectrum, clinical and virology/epidemiology, we invite you to contribute to this Special Issue with your original research or review articles.
Dr. Giota Lourida
Prof. Dr. Dimitrios Paraskevis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV
- antiretroviral treatment
- long-acting ART
- pre-exposure prophylaxis
- HIV surveillance
- antiretroviral resistance
- primary resistance
- HIV epidemiology
- special populations
- cascade of care
- HIV diagnosis
